- Home
- EHC vs GMED Comparison
EHC vs GMED Comparison
Compare EHC & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHC
- GMED
- Stock Information
- Founded
- EHC 1983
- GMED 2003
- Country
- EHC United States
- GMED United States
- Employees
- EHC N/A
- GMED N/A
- Industry
- EHC Hospital/Nursing Management
- GMED Medical/Dental Instruments
- Sector
- EHC Health Care
- GMED Health Care
- Exchange
- EHC Nasdaq
- GMED Nasdaq
- Market Cap
- EHC N/A
- GMED 8.1B
- IPO Year
- EHC 1986
- GMED 2012
- Fundamental
- Price
- EHC $119.04
- GMED $59.17
- Analyst Decision
- EHC Strong Buy
- GMED Buy
- Analyst Count
- EHC 8
- GMED 13
- Target Price
- EHC $123.38
- GMED $94.30
- AVG Volume (30 Days)
- EHC 662.2K
- GMED 1.2M
- Earning Date
- EHC 08-04-2025
- GMED 08-05-2025
- Dividend Yield
- EHC 0.57%
- GMED N/A
- EPS Growth
- EHC 30.58
- GMED 145.70
- EPS
- EHC 4.84
- GMED 1.34
- Revenue
- EHC $5,512,600,000.00
- GMED $2,510,810,000.00
- Revenue This Year
- EHC $10.73
- GMED $15.47
- Revenue Next Year
- EHC $8.61
- GMED $8.97
- P/E Ratio
- EHC $24.49
- GMED $44.29
- Revenue Growth
- EHC 11.21
- GMED 32.26
- 52 Week Low
- EHC $82.74
- GMED $54.48
- 52 Week High
- EHC $123.13
- GMED $94.93
- Technical
- Relative Strength Index (RSI)
- EHC 47.24
- GMED 47.52
- Support Level
- EHC $117.52
- GMED $57.79
- Resistance Level
- EHC $123.00
- GMED $61.29
- Average True Range (ATR)
- EHC 2.04
- GMED 1.28
- MACD
- EHC -0.40
- GMED 0.43
- Stochastic Oscillator
- EHC 29.29
- GMED 60.51
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.